Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema

References

• Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010;39:257–268.
   PubMed Web of Science ®Google Scholar
• Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clinic Rev Allerg Immunol.. 2011;40:42–49.
   PubMed Web of Science ®Google Scholar
• Unterman A, Nolte JE, Boaz M, et al. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41:1–11.
   PubMed Web of Science ®Google Scholar
• The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.
   PubMed Web of Science ®Google Scholar
• Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis. 2012;2012:876456.
   PubMedGoogle Scholar
• Hirohata S, Sakuma Y, Matsueda Y, et al. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol. 2018;36:1003–1007.
   PubMed Web of Science ®Google Scholar
• Sakuma Y, Nagai T, Yoshio T, et al. Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus. Mod Rheumatol. 2017;27:292–297.
   PubMed Web of Science ®Google Scholar
• Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 1990;33:644–649.
   PubMed Web of Science ®Google Scholar
• Shiozawa S, Kuroki Y, Kim M, et al. Interferon-alpha in lupus psychosis. Arthritis Rheum. 1992;35:417–422.
   PubMed Web of Science ®Google Scholar
• Faria R, Goncalves J, Dias R. Neuropsychiatric systemic lupus erythematosus involvement: towards a tailored approach to our patients? Rambam Maimonides Med J. 2017;8:e0001.
   Web of Science ®Google Scholar
• Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA.. 2006;103:678–683.
   PubMed Web of Science ®Google Scholar
• Sarbu N, Bargallo N, Cervera R. Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus. F1000Res. 2015;4:162.
   Google Scholar
• Lee SY, Chu K, Park KI, et al. Diffusion-weighted MR findings in isolated angiitis of the central nervous system (IACNS). Acta Neurol Scand. 2003;108:346–351.
   Web of Science ®Google Scholar
• Ho ML, Rojas R, Eisenberg RL. Cerebral edema. AJR Am J Roentgenol. 2012;199:W258–W273.
   Web of Science ®Google Scholar
• Luyendijk J, Steens SC, Ouwendijk WJ, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 2011;63:722–732.
   PubMed Web of Science ®Google Scholar
• Arinuma Y, Kikuchi H, Wada T, et al. Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Lupus Sci Med. 2014;1:e000050.
   PubMedGoogle Scholar
• Hirohata S, Kanai Y, Mitsuo A, et al. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol. 2009;28:1319–1323.
   PubMed Web of Science ®Google Scholar
• Brownlee WJ, Hardy TA, Fazekas F, et al. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389:1336–1346.
   PubMed Web of Science ®Google Scholar
• Hardy TA, Reddel SW, Barnett MH, et al. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15:967–981.
   PubMed Web of Science ®Google Scholar
• Marin SE, Callen DJ. The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria. Neuroimaging Clin N Am. 2013;23:245–266.
   PubMed Web of Science ®Google Scholar
• Ordonez L, Skromne E, Ontaneda D, et al. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg. 2007;109:102–105.
   PubMed Web of Science ®Google Scholar
• Shintaku M, Matsumoto R. Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: report of an autopsy case. Acta Neuropathol. 1998;95:313–317.
   Web of Science ®Google Scholar
• Sosenko T, Musetescu A, Gandhi N, et al. Case review: lupus patient with acute disseminating encephalomyelitis. The Rheumatologist. 2018. Available from: https://www.the-rheumatologist.org/article/case-review-lupus-patient-acute-disseminating-encephalomyelitis/
   Google Scholar
• Sato S, Nakajima J, Shimura M, et al. Reversible basal ganglia lesions in neuropsychiatric lupus: a report of three pediatric cases. Int J Rheum Dis. 2014;17:274–279.
   Web of Science ®Google Scholar
• Bhagavati S, Choi J. Reversible basal ganglia and amygdala lesions in central nervous system lupus. J Rheumatol. 2008;35:2451–2453.
   Web of Science ®Google Scholar
• Lin WY, Wang SJ, Yen TC, et al. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med. 1997;38:1112–1115.
   PubMed Web of Science ®Google Scholar
• Dale RC, de SC, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123:2407–2422.
   PubMed Web of Science ®Google Scholar
• Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56:1313–1318.
   PubMed Web of Science ®Google Scholar
• Tenembaum SN. Acute disseminated encephalomyelitis. Handb Clin Neurol. 2013;112:1253–1262.
   Google Scholar
• Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol. 2001;50:588–595.
   PubMed Web of Science ®Google Scholar
• Dale RC, Brilot F. Autoimmune basal ganglia disorders. J Child Neurol. 2012;27:1470–1481.
   PubMed Web of Science ®Google Scholar
• Al Jishi F, Al Kawi MZ, el Ramahi K, et al. Hemichorea in systemic lupus erythematosus: significance of MRI findings. Lupus. 1995;4:321–323.
   Web of Science ®Google Scholar
• Shahar E, Goshen E, Tauber Z, et al. Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol. 1998;18:456–458.
   PubMed Web of Science ®Google Scholar
• Kwong KL, Chu R, Wong SN. Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus. Lupus. 2000;9:474–477.
   PubMed Web of Science ®Google Scholar
• Wu K, Christodoulou L, Siddiqui A, et al. Bilateral reversible basal ganglia changes associated with dystonia and hemifacial spasms in central nervous system lupus. Quant Imaging Med Surg. 2015;5:928–929.
   Google Scholar
• Romba M, Wang Y, Hu SC, et al. Jaw dystonia and reversible basal ganglia changes as an initial presentation of systemic lupus erythematosus. Neurohospitalist. 2018;8:31–34.
   Web of Science ®Google Scholar
• Shibata M, Kibe T, Fujimoto S, et al. Diffuse central nervous system lupus involving white matter, basal ganglia, thalami and brainstem. Brain Dev. 1999;21:337–340.
   Web of Science ®Google Scholar
• Torreggiani S, Torcoletti M, Cuoco F, et al. Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports. Pediatr Rheumatol. 2013;11:36.
   Web of Science ®Google Scholar
• Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997;76:203–212.
   PubMed Web of Science ®Google Scholar
• Lim MK, Suh CH, Kim HJ, et al. Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. Radiology. 2000;217:43–49.
   Web of Science ®Google Scholar
• Guttman M, Lang AE, Garnett ES, et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord. 1987;2:201–210.
   Google Scholar
• Kovacs JA, Urowitz MB, Gladman DD, et al. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol. 1995;22:1247–1253.
   PubMed Web of Science ®Google Scholar
• Otte A, Weiner SM, Peter HH, et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med. 1997;24:787–791.
   Google Scholar
• Ogasawara A, Kakeda S, Watanabe K, et al. Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia. Eur Radiol. 2016;26:1056–1063.
   Web of Science ®Google Scholar
• Zhang Z, Wang Y, Shen Z, et al. The neurochemical and microstructural changes in the brain of systemic lupus erythematosus patients: a multimodal MRI study. Sci Rep. 2016;6:19026.
   Web of Science ®Google Scholar
• Niu N, Cui R. Glucose hypermetabolism in contralateral basal ganglia demonstrated by serial FDG PET/CT scans in a patient with SLE chorea. Clin Nucl Med. 2017;42:64–65.
   PubMed Web of Science ®Google Scholar
• Nordstrom DM, West SG, Andersen PA. Basal ganglia calcifications in central nervous system lupus erythematosus. Arthritis Rheum. 1985;28:1412–1416.
   Google Scholar
• Raymond AA, Zariah AA, Samad SA, et al. Brain calcification in patients with cerebral lupus. Lupus. 1996;5:123–128.
   Web of Science ®Google Scholar
• Filloux V, Marotte H, Miossec P. Cerebral calcifications in an elderly lupus patient. Ann Rheum Dis. 2003;62:283–284.
   Web of Science ®Google Scholar
• Go JL, Zee CS. Unique CT imaging advantages. Hemorrhage and calcification. Neuroimaging Clin N Am. 1998;8:541–558.
   PubMed Web of Science ®Google Scholar
• van Schaarenburg RA, Magro-Checa C, Bakker JA, et al. C1q deficiency and neuropsychiatric systemic lupus erythematosus. Front Immunol. 2016;7:647.
   PubMed Web of Science ®Google Scholar
• Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69:2074–2082.
   PubMed Web of Science ®Google Scholar
• Chi JM, Mackay M, Hoang A, et al. Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus. AJNR Am J Neuroradiol. 2019;40:470–477.
   PubMed Web of Science ®Google Scholar
• Sibbitt WL, Brooks WM. Systemic lupus erythematosus: anatomic and functional imaging studies. In: Erkan D, Levine SR, eds. Handbook of systemic autoimmune diseases. Vol. 3. Amsterdam: Elsevier; 2004. p. 45–68.
   Google Scholar
• Miller DH, Buchanan N, Barker G, et al. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J Neurol. 1992;239:460–464.
   Web of Science ®Google Scholar